{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/balanitis/management/balanitis-adults/","result":{"pageContext":{"chapter":{"id":"44e5d982-e2af-5996-ab20-fcc33b89adf1","slug":"balanitis-adults","fullItemName":"Scenario: Balanitis - adults","depth":2,"htmlHeader":"<!-- begin field 09e481fe-2f6a-43fc-9da0-26f736219204 --><h2>Scenario: Balanitis - adults</h2><!-- end field 09e481fe-2f6a-43fc-9da0-26f736219204 -->","summary":"Covers the management of suspected or confirmed balanitis in young men and adults 16 years of age and older in primary care.","htmlStringContent":"<!-- begin item 05630d9d-88a6-4f49-89f4-eea87aa4b780 --><!-- begin field d5a88cc3-ab8f-452c-8a8f-acbc0157ea37 --><p>From age 16 years onwards (Male).</p><!-- end field d5a88cc3-ab8f-452c-8a8f-acbc0157ea37 --><!-- end item 05630d9d-88a6-4f49-89f4-eea87aa4b780 -->","topic":{"id":"4da8d9db-f350-588f-83e8-f5efc3335305","topicId":"eb6c6cd9-3331-4790-a1f9-a11ed643b2b0","topicName":"Balanitis","slug":"balanitis","lastRevised":"Last revised in October 2018","chapters":[{"id":"cf843687-5035-5956-aa14-3d8bacbd404f","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"41d01ca1-763c-529e-8026-28dd85d36b16","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b9dae5ef-34a6-57ed-bf21-9b9543370ecd","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"2fc17559-2630-5868-aeda-16c7394d8223","slug":"changes","fullItemName":"Changes"},{"id":"699e0434-3685-5acc-9956-84bc269b6ae0","slug":"update","fullItemName":"Update"}]},{"id":"e0b4a9d5-30c1-589c-b52c-49a537ed88cf","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"045bf9d9-1913-57d7-85ac-7dd14d9a6ad1","slug":"goals","fullItemName":"Goals"},{"id":"9242a4e0-3dd3-598a-8015-c1fd35c8ae24","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8d94eba3-36ae-5c38-b3bd-c6fe5a1d1122","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"9c3fec0e-6d36-590b-a67a-9fde96b588b6","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"dd19254a-f9ef-5cd1-af7b-f5226c2474da","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"5cc7acd3-6e1c-5b23-9f58-aa1a50f67faa","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"10c99e35-8476-5d3d-a309-c80fc5ed5fa7","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"e615c22a-91ed-5f2c-8d1b-657c4409d5ff","slug":"definition","fullItemName":"Definition"},{"id":"93cf765a-7e94-5ba7-bc6c-d001406aa393","slug":"causes","fullItemName":"Causes"},{"id":"8f5ac951-0e46-5c89-9a50-27eb3f65076f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"feeb11e3-9d66-5d96-a507-c526af44a7f0","slug":"complications","fullItemName":"Complications"}]},{"id":"fb758dfb-b24b-5875-9570-5d6b29ad0606","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"7f4b11b8-626e-56eb-9a8d-5aafbb365797","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"e0d6dde7-d713-5601-94f9-9a443f7c7cb3","slug":"assessment","fullItemName":"Assessment"},{"id":"a1bd5ccf-b828-59e7-893c-ab9d9e755750","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"de355ac0-0522-5d92-a913-4694aa861fd7","fullItemName":"Management","slug":"management","subChapters":[{"id":"bd1e001e-c6a9-5d54-88ca-ce4a56b46edd","slug":"balanitis-children","fullItemName":"Scenario: Balanitis - children"},{"id":"44e5d982-e2af-5996-ab20-fcc33b89adf1","slug":"balanitis-adults","fullItemName":"Scenario: Balanitis - adults"}]},{"id":"3fdc0cf3-e98c-5a04-9525-c21e93db6dad","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"7db80726-7da5-5db6-85b2-e6a211cd3278","slug":"topical-imidazoles","fullItemName":"Topical imidazoles"},{"id":"ad41f201-03ec-5da9-ac6a-1902fa6cad6c","slug":"oral-fluconazole","fullItemName":"Oral fluconazole"},{"id":"29db55e2-6292-57cc-bb96-e0331bea331b","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"41cf5c1f-073b-55f6-bca1-f483e1e31783","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"e2c0e955-b610-5ee0-83a7-020247e8d2e3","slug":"metronidazole","fullItemName":"Metronidazole"}]},{"id":"8384c8ca-522a-546a-971b-71a12dc40ba9","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"1946dc01-8848-5119-a228-39e16c9c2fee","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a80a505e-c0ca-5472-966a-cfb4d225c502","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f260f355-769f-5d83-8c42-f5b606d7cab7","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"bedff117-4d2b-5b3b-ae77-431100374dfe","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ccf2a0ba-1a8a-5d6c-829c-a90817d3a0cb","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"c09916ae-40e4-5285-8ce4-a0995eb5225b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"fcdbbdd1-c423-5b0c-b610-1ba72cc625c9","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"de355ac0-0522-5d92-a913-4694aa861fd7","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"a946ae40-9452-5cbd-8abd-182b12c82156","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field f6375dbd-4267-43b6-badf-a87000e6b333 --><h3>How should I manage an adult with balanitis?</h3><!-- end field f6375dbd-4267-43b6-badf-a87000e6b333 -->","summary":null,"htmlStringContent":"<!-- begin item e36c7a81-d41b-449d-863e-a87000e6ac19 --><!-- begin field f28f7e19-b154-4658-a4f3-a87000e6b333 --><p><strong>If a young man or adult has <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/diagnosis/diagnosis/\">suspected balanitis</a>:</strong></p><ul><li><strong>Advise the person to clean under the foreskin daily</strong> with lukewarm water and to dry it gently.<ul><li>Do not use soap or bubble bath which may irritate the area.</li><li>Consider an emollient (such as emulsifying ointment) as a soap substitute.</li></ul></li><li><strong>Advise on sources of written information and support,</strong> such as:<ul><li>The NHS information leaflet on <a data-hyperlink-id=\"1ef95d87-e1ff-46bc-a072-a992008e021b\" href=\"https://www.nhs.uk/conditions/balanitis/\" target=\"_blank\">Balanitis</a>.</li><li>The Patient.info information leaflet on <a data-hyperlink-id=\"f1b813f0-41b1-4b40-ad38-a992008e0238\" href=\"https://patient.info/health/balanitis-leaflet\" target=\"_blank\">Balanitis</a>.</li></ul></li><li><strong>For suspected non-specific dermatitis:</strong><ul><li>Prescribe topical hydrocortisone 1% cream or ointment once a day and an imidazole cream, the frequency depending on the preparation used, until symptoms settle or for up to 14 days.<ul><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/\">Corticosteroids - topical (skin), nose, and eyes</a> for more information.</li><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/topical-imidazoles/\">Topical imidazoles</a> in the section on <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/\">Prescribing information</a> for more information.</li><li>Advise that topical imidazole preparations may damage latex condoms and diaphragms.</li></ul></li></ul></li><li><strong>For suspected irritant or allergic contact dermatitis:</strong><ul><li>Advise the person to stop any suspected triggers (such as soap, bubble bath, latex condoms, lubricants, or creams).</li><li>Prescribe topical hydrocortisone 1% cream or ointment once a day until symptoms settle, or for up to 14 days.<ul><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/\">Corticosteroids - topical (skin), nose, and eyes</a> for more information.</li></ul></li><li><strong> </strong>Advise on the use of a regular emollient and use as a soap substitute. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dermatitis-contact/\">Dermatitis - contact</a> for more information.</li></ul></li><li><strong>For suspected or confirmed candidal balanitis:</strong><ul><li>Prescribe an imidazole cream, the frequency depending on the preparation used, until symptoms settle or for up to 14 days, <em>or</em></li><li>Prescribe oral fluconazole 150 mg as a single dose<ul><li>See the sections on <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/topical-imidazoles/\">Topical imidazoles</a> and <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/oral-fluconazole/\">Oral fluconazole</a> in the section on <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/\">Prescribing information</a> for more information.</li><li>Advise that topical imidazole preparations may damage latex condoms and diaphragms.</li></ul></li><li>If inflammation is causing discomfort, consider prescribing topical hydrocortisone 1% cream or ointment for up to 14 days in addition.<ul><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/\">Corticosteroids - topical (skin), nose, and eyes</a> for more information.</li></ul></li><li>If there is confirmed recurrent candidal balanitis:<ul><li>Consider advising on testing for Candida infection in any sexual partner(s), to reduce the potential reservoir of infection. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/candida-female-genital/\">Candida - female genital</a> for more information, if appropriate.</li></ul></li></ul></li><li><strong>For suspected or confirmed bacterial balanitis:</strong><ul><li>Prescribe oral flucloxacillin 500 mg four times a day for seven days. If the person is allergic to penicillin, prescribe oral clarithromycin 250 mg twice daily for seven days.<ul><li>See the sections on <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/flucloxacillin/\">Flucloxacillin</a> and <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/clarithromycin/\">Clarithromycin</a> in the section on <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/\">Prescribing information</a> for more information.</li></ul></li><li>If inflammation is causing discomfort, consider prescribing topical hydrocortisone 1% cream or ointment for up to 14 days in addition.<ul><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/\">Corticosteroids - topical (skin), nose, and eyes</a> for more information.</li></ul></li><li>If there is confirmed recurrent Streptococcal balanitis:<ul><li>Consider advising on testing for Streptococcal infection in any sexual partner(s), to reduce the potential reservoir of infection.</li></ul></li></ul></li><li><strong>For suspected or confirmed anaerobic (Gardnerella) balanitis:</strong><ul><li>Prescribe oral metronidazole 400 mg twice a day for seven days.<ul><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/metronidazole/\">Metronidazole</a> in the section on <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/prescribing-information/\">Prescribing information</a> for more information.</li></ul></li><li>If inflammation is causing discomfort, consider prescribing topical hydrocortisone 1% cream or ointment for up to 14 days in addition.<ul><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/\">Corticosteroids - topical (skin), nose, and eyes</a> for more information.</li></ul></li><li>If there is confirmed recurrent Gardnerella balanitis:<ul><li>Consider advising on testing for Gardnerella infection in any sexual partner(s), to reduce the potential reservoir of infection. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/bacterial-vaginosis/\">Bacterial vaginosis</a> for more information, if appropriate.</li></ul></li></ul></li><li><strong>For suspected seborrhoeic dermatitis,</strong> see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/seborrhoeic-dermatitis/\">Seborrhoeic dermatitis</a> for more information on management.</li><li><strong>For suspected genital psoriasis,</strong> see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/psoriasis/\">Psoriasis</a> for more information on management.</li><li><strong>For a suspected or confirmed <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/background-information/causes/\">sexually transmitted infection</a>,</strong> arrange <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/management/balanitis-adults/#referral\">referral</a> to a sexual health clinic or manage in primary care, as appropriate.</li><li><strong>For all other possible <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/background-information/causes/\">underlying causes</a> of balanitis,</strong> or if there is any uncertainty regarding the diagnosis, arrange specialist <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/management/balanitis-adults/#referral\">referral</a> for further assessment and management. </li><li><strong>If symptoms are not improving following seven days of initial treatment:</strong><ul><li>Stop treatment with topical hydrocortisone (if using).</li><li>Take a sub-preputial swab to exclude or confirm a fungal or bacterial infection, and treat accordingly. Be aware that:<ul><li>Group B streptococcus is usually a commensal and does not usually need treatment.</li><li>Candida may be a superadded infection and its presence does not exclude an underlying skin condition.</li></ul></li></ul></li><li><strong>Arrange a blood test for HbA1c to assess for underlying diabetes mellitus and HIV</strong> (if appropriate), if balanitis is severe, persistent, or recurrent (especially if candidal balanitis is present). See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-1/\">Diabetes - type 1</a>, <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-2/\">Diabetes - type 2</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/hiv-infection-aids/\">HIV infection and AIDS</a> for more information.</li></ul><!-- end field f28f7e19-b154-4658-a4f3-a87000e6b333 --><!-- end item e36c7a81-d41b-449d-863e-a87000e6ac19 -->","subChapters":[{"id":"5b3b0a4f-b204-50a9-9970-8b694942bf43","slug":"basis-for-recommendation-4f9","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 7f03b6c3-60a7-4709-b843-a87000e6b3f0 --><h4>Basis for recommendation</h4><!-- end field 7f03b6c3-60a7-4709-b843-a87000e6b3f0 -->","summary":null,"htmlStringContent":"<!-- begin item 4f972dbf-6f3b-4bd0-bed8-a87000e6b3a8 --><!-- begin field 39c14328-eb95-48b8-b0ad-a87000e6b3f0 --><p>The recommendations on management are largely based on expert opinion in the <em>2013 European guideline for the management of balanoposthitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Edwards, 2014</a>], expert opinion in the Royal College of General Practitioners and British Association of Sexual Health and HIV (RCGP/BASHH) publication <em>Sexually transmitted infections in primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Lazaro, 2013</a>], expert opinion in review articles on male genital skin conditions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">English et al, 1997</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Shim, 2016</a>] and on penile inflammatory skin disorders [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Morris, 2017</a>].</p><ul><li>CKS found no evidence for the comparative effectiveness of different topical imidazole preparations for the management of balanitis.</li><li>The information on imidazole creams potentially damaging condoms is based on expert opinion in the European guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Edwards, 2014</a>], the RCGP/BASHH publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Lazaro, 2013</a>], and expert opinion in the British National Formulary [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">BNF 74, 2017</a>].</li><li>The recommendation to offer testing for Candida infection in sexual partners of men with confirmed recurrent candidal balanitis is based on expert opinion in the European guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Edwards, 2014</a>] and in the RCGP/BASHH publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Lazaro, 2013</a>], as there is a high rate of candidal infection in sexual partners which may act as a reservoir for reinfection.</li><li>The recommendation on the use of flucloxacillin for suspected or confirmed bacterial balanitis is pragmatic based on what CKS considers to be good clinical practice, as this antibiotic has activity against group A beta-haemolytic streptococci and <em>Staphylococcus aureus</em>. It is also based on the expert opinion of previous external reviewers of this CKS topic.</li><li>The recommendation to offer testing for Streptococcus in sexual partners of men with confirmed recurrent Streptococcal balanitis is based on the fact that the primary reservoir for group B beta-haemolytic streptococci is the female genital tract, and sexual transmission is the most likely cause of streptococcal balanitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">English et al, 1997</a>].</li><li>The recommendation to offer testing for Gardnerella infection in sexual partners of men with confirmed recurrent Gardnerella balanitis is based on the expert opinion of previous external reviewers of this CKS topic.</li><li>The recommendations on the significance of culture of group B streptococcus and candida following sub-preputial swabbing are based on expert opinion in the RCGP/BASHH publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Lazaro, 2013</a>] and the European guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Edwards, 2014</a>].</li><li>The recommendation on considering and assessing for causes of immunosuppression such as diabetes mellitus and HIV if balanitis is severe or persistent is based on expert opinion in the European guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Edwards, 2014</a>] and in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Morris, 2017</a>].</li></ul><!-- end field 39c14328-eb95-48b8-b0ad-a87000e6b3f0 --><!-- end item 4f972dbf-6f3b-4bd0-bed8-a87000e6b3a8 -->","subChapters":[]}]},{"id":"a62415de-0016-5fc7-8c80-1d49045325e0","slug":"referral","fullItemName":"Referral","depth":3,"htmlHeader":"<!-- begin field 05b5ad76-2e3d-4d56-bfef-a87000e7fb53 --><h3>When should I refer an adult with balanitis?</h3><!-- end field 05b5ad76-2e3d-4d56-bfef-a87000e7fb53 -->","summary":null,"htmlStringContent":"<!-- begin item d6072d30-6fe6-4f3f-966f-a87000e7f658 --><!-- begin field 31893371-631e-421c-920c-a87000e7fb53 --><ul><li><strong>Arrange referral to a dermatologist, sexual health specialist, or urologist, depending on the most likely <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/background-information/causes/\">underlying cause</a> using clinical judgement, if:</strong><ul><li>The diagnosis is uncertain.</li><li>Balanitis is persistent and does not respond to initial management in primary care.</li><li>Balanitis is recurrent and associated with inability to retract the foreskin (phimosis) — refer to a urologist for consideration of circumcision.</li><li>Balanitis is recurrent and no underlying cause is found.</li><li>There is suspected allergic contact dermatitis — refer to a dermatologist for consideration of patch testing. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dermatitis-contact/\">Dermatitis - contact</a> for more information.</li><li>There is suspected Zoon's balanitis — a penile biopsy may be needed to exclude a <a class=\"topic-reference internal-reference\" href=\"/topics/balanitis/background-information/causes/\">pre-malignant condition</a>, which may present similarly.</li><li>There is suspected lichen sclerosus — specialist assessment may be needed as there is a small risk of malignant transformation.</li><li>There is a suspected sexually transmitted infection (STI) — refer to a sexual health clinic for further assessment and management.</li><li>There is a penile mass or ulcerated lesion, where an STI has been excluded as a cause, or there is a persistent penile lesion after treatment for an STI has been completed — to exclude a pre-malignant penile condition or penile malignancy. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/urological-cancers-recognition-referral/\">Urological cancers - recognition and referral</a> for more information.</li></ul></li></ul><!-- end field 31893371-631e-421c-920c-a87000e7fb53 --><!-- end item d6072d30-6fe6-4f3f-966f-a87000e7f658 -->","subChapters":[{"id":"42a7208d-2712-5adc-b6dd-03267824a03c","slug":"basis-for-recommendation-496","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 1614baa9-09e3-46bd-9664-a87000e7fb5e --><h4>Basis for recommendation</h4><!-- end field 1614baa9-09e3-46bd-9664-a87000e7fb5e -->","summary":null,"htmlStringContent":"<!-- begin item 496b5355-acdd-4583-8adc-a87000e7fb5e --><!-- begin field 3e8e2202-313c-466d-994d-a87000e7fb5e --><p>The recommendations on referral are based on expert opinion in the National Institute for Health and Care Excellence (NICE) clinical guideline <em>Suspected cancer: recognition and referral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">NICE, 2015</a>], expert opinion in the <em>2013 European guideline for the management of balanoposthitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Edwards, 2014</a>], expert opinion in the Royal College of General Practioners and British Association for Sexual Health and HIV (RCGP/BASHH) publication <em>Sexually Transmitted Infections in Primary Care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Lazaro, 2013</a>], the British Association of Dermatologists' (BAD) <em>Guidelines for the management of lichen sclerosus 2010</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">BAD, 2010</a>], and expert opinion in a review article on benign male genital skin conditions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Shim, 2016</a>].</p><ul><li>If balanitis is persistent and does not respond to initial management in primary care, a penile biopsy may be needed to exclude pre-malignant or malignant disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Edwards, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Shim, 2016</a>].</li><li>Lichen sclerosus needs specialist followup as there is a risk of malignant transformation (male genital lichen sclerosus is associated with about 50% of cases of penile squamous cell carcinoma) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Lazaro, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Shim, 2016</a>]. It may also lead to complications such as phimosis, meatal stenosis, or urethral stricture, which may require surgical management such as circumcision, meatotomy, or urethroplasty [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">BAD, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Edwards, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Shim, 2016</a>].</li><li>Any new warty or papular lesions, persistent ulcers, erosions, hyperkeratosis, and fixed erythematous areas in men with genital lichen sclerosus or lichen planus need specialist referral to exclude malignant change [<a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">BAD, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/balanitis/references/\">Shim, 2016</a>].</li></ul><!-- end field 3e8e2202-313c-466d-994d-a87000e7fb5e --><!-- end item 496b5355-acdd-4583-8adc-a87000e7fb5e -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}